Chris Baglieri is the SVP of Technology at BlackFynn, a technology-driven life sciences company that helps the neuroscience and neurology communities make optimal use of data.
Gathering, cleaning, manipulating, and assessing data is a complex (and expensive) job – especially if the data takes a wide variety of forms, and comes from many different sources. So what’s the benefit for companies to invest in that work?
In this interview, Chris and Tracey Welson-Rossman talk about bridging the gap between biotech and ‘tech’ tech disciplines, and the unique challenges – and advantages – to harnessing biotech data.
More Resources
- Our entire 15 Minutes With playlist on YouTube: covering everything from biotech, to AR, to manufacturing, and more.
- Chris Baglieri’s GitHub account
- An article about Blackfynn’s partnership with the Michael J. Fox Foundation
Is there anything you’d like us to discuss in this series? Email info@chariotsolutions.com, or leave a thought below.